OneMedNet Expands Multiple Revenue-Delivering Projects Under Evergreen Agreement With Top Medical Device Leader

Rhea-AI Summary

OneMedNet (Nasdaq:ONMD) has expanded its partnership with one of the world's top five medical device companies through multiple revenue-generating projects under an evergreen master services agreement. The collaboration includes four distinct purchase orders focused on delivering regulatory-grade multimodal Real-World Data (RWD) to accelerate medical imaging AI model development.

The company leverages its iRWD™ network spanning over 1,750 provider sites to deliver comprehensive datasets that include advanced medical imaging data and complete patient histories. OneMedNet has already begun fulfilling these recent orders, demonstrating its efficient execution capabilities in providing curated, de-identified, and fit-for-purpose datasets for AI development, clinical trial enhancement, and healthcare outcome improvement.

Positive

• Secured multiple revenue-generating projects with a top 5 global medical device leader
• Evergreen master services agreement provides ongoing business potential with no fixed term
• Extensive network coverage with over 1,750 provider sites
• Demonstrated ability to quickly execute and deliver on new orders

Negative

• Specific revenue figures and contract values not disclosed
• Heavy dependence on single large customer relationship

Insights

Healthcare Data Analytics Expert

OneMedNet secures multiple revenue streams through expanded partnership with top-5 medical device leader, demonstrating strong market position in healthcare AI data.

OneMedNet's announcement represents a significant commercial expansion with one of healthcare's most influential players. The evergreen master services agreement is particularly valuable as it establishes an ongoing revenue relationship without a fixed termination date, reducing customer acquisition costs and providing greater revenue predictability.

The four separate purchase orders indicate diverse use cases for OneMedNet's real-world data, suggesting their platform has multiple applications within a single organization. This demonstrates product versatility and increases potential wallet share from each customer. The immediate commencement of delivery on these orders confirms operational readiness and suggests near-term revenue recognition.

What truly differentiates OneMedNet in the competitive healthcare data landscape is their multimodal data offering. By combining advanced medical imaging with comprehensive patient histories and clinical notes, they're delivering the contextual richness necessary for developing sophisticated AI models. This comprehensive approach addresses a critical challenge in healthcare AI development – the need for diverse, interconnected data types that reflect real-world clinical scenarios.

The company's network spanning 1,750+ provider sites represents a substantial competitive moat. Building such extensive provider relationships requires significant time investment and regulatory navigation, creating barriers to entry for competitors. The emphasis on regulatory-grade data quality further strengthens their market position, particularly for customers developing products requiring FDA or other regulatory approvals.

MINNEAPOLIS, Aug. 25, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announces significant adoption by one of the world’s top five medical device leaders. Renowned for its cutting-edge diagnostic imaging systems, clinical software, and digital health solutions, this global innovator is recognized for advancing precision medicine and improving patient outcomes worldwide.

There is a master services agreement in place providing for an evergreen engagement with no fixed term. Current deliverables include four distinct purchase orders for OneMedNet’s Real-World Data, each focused on delivering diverse, regulatory grade multi modal data to accelerate innovation in medical imaging AI model development. These agreements reflect the strength, reliability, and clinical integrity of OneMedNet’s data, which meets the rigorous quality standards demanded by the world’s most trusted healthcare brands.

“Real-World Evidence can only be generated from comprehensive, multimodal data sets. OneMedNet is uniquely positioned to deliver not only advanced medical imaging data but also the full depth of patient histories and provider notes from our partners’ electronic health records,” said Aaron Green, President and CEO of OneMedNet. “Our ability to provide the most current, large-scale data across our growing partner network is what continues to drive repeat business and long-term customer trust.”

OneMedNet has already begun to fulfill these most recent orders, underscoring its ability to move from agreement to delivery quickly and effectively. The projects leverage OneMedNet’s expansive iRWD™ network, encompassing clinical data sourced from over 1,750 provider sites.

By delivering curated, de-identified, and fit-for-purpose datasets, OneMedNet empowers its customers to accelerate AI development, enhance clinical trial design, and improve healthcare outcomes at scale.

About OneMedNet Corporation

OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.

Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. We base these forward-looking statements on our current expectations and projections about future events, which we derive from the information presently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations..

OneMedNet Contacts:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

SOURCE: ONEMEDNET CORPORATION

FAQ

What new contracts did OneMedNet (ONMD) announce with the medical device company?

OneMedNet announced four distinct purchase orders under an evergreen master services agreement for delivering regulatory-grade multimodal Real-World Data to support medical imaging AI model development.

How many provider sites are in OneMedNet's iRWD™ network?

OneMedNet's iRWD™ network encompasses clinical data from over 1,750 provider sites.

What type of data does OneMedNet (ONMD) provide to its customers?

OneMedNet provides curated, de-identified, and fit-for-purpose datasets that include advanced medical imaging data, complete patient histories, and provider notes from electronic health records.

How does OneMedNet's data help in healthcare development?

OneMedNet's Real-World Data helps customers accelerate AI development, enhance clinical trial design, and improve healthcare outcomes through comprehensive, multimodal datasets that meet rigorous quality standards.

Who is the CEO of OneMedNet (ONMD)?

Aaron Green serves as the President and CEO of OneMedNet.